94.4%
Fox Chase Cancer CentermelanomaNumidargistatcutaneous melanomaCB-1158HY-P71833
…nd was approved by our institutional research ethics committee (Fox Chase Cancer Center, Philadelphia, USA; protocols #23-05; OLAW #D16-00184).…
4articles mentioning institutions
4institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: Fox Chase Cancer Center ×
Fox Chase Cancer Center
This institution is selected. Its supporting articles are shown below.
Articles mentioning Fox Chase Cancer Center
4 articles · page 1 of 1Fox Chase Cancer CenterMelanomaPROS1
…nd was approved by our institutional research ethics committee (Fox Chase Cancer Center, Philadelphia, USA; protocols #23-05; OLAW #D16-00184).…
93.8%
Fox Chase Cancer Centermelanomacheckpoint inhibitorsICIs
…nd was approved by our institutional research ethics committee (Fox Chase Cancer Center, Philadelphia, USA; protocols #23-05; OLAW #D16-00184).…
University of VirginiaFox Chase Cancer CenterMD Anderson Cancer CenterUniversity of Texas – Houston6MHPmelanomaClinicalTrials.govcyclophosphamiderecurrent tumors12MP
…sity of Texas – Houston, and Fox Chase Cancer Center), with the University of Virginia at the lead institution; approval number: IRB-HSR #11491.Abstra…